Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
Moleculin Accelerates Outlook Into 2026 With First Pivotal Trial Unblinding on Track, Global Trial Expansion, and Multiple Externally/IIT Funded Clinical Programs
GlobeNewswire, Inc.
– First MIRACLE trial unblinding expected Q1 2026; Global trial now spans nine countries – Investigator-Initiated (IIT) funded pancreatic and brain cancer trials HOUSTON, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX)...
HRF files war crimes complaint against Israeli soldier in Czech Republic
MENAFN
(MENAFN) The Hind Rajab Foundation (HRF) announced on Friday that it has filed a criminal complaint in the Czech Republic against an Israeli soldier accused of committing war crimes and acts of genocide in the Gaza Strip.
uLékaře.cz, s.r.o. Forms a Strategic Partnership with Mavie, a European Leader in Holistic Healthcare
EIN Presswire
The investment aims to offer companies in the CEE region even more comprehensive, digital, and holistic health solutions from a single source in the future.
Chiesi Group and Arbor Biotechnologies Announce ABO-101 Granted Orphan Drug Designation by European Commission for Primary Hyperoxaluria
GlobeNewswire, Inc.
ABO-101 is an investigational gene editing therapy designed to address the underlying disease biology of PH1 by reducing hepatic oxalate production Orphan Drug Designation (ODD) highlights the need for additional treatment options for people...
ACA Pharma Announces Major Expansion of RYANODEX® Territory Outside the United States
EIN Presswire
Expanded collaboration significantly broadens ACA Pharma’s ex-U.S. commercialization footprint for RYANODEX® NEW YORK, NY, UNITED STATES, November 24, 2025 /EINPresswire.com/ -- ACA Pharma today announced a significant expansion of their...
Chiesi Group and Arbor Biotechnologies Announce ABO-101 Granted Orphan Drug Designation by European Commission for Primary Hyperoxaluria
GlobeNewswire, Inc.
ABO-101 is an investigational gene editing therapy designed to address the underlying disease biology of PH1 by reducing hepatic oxalate production Orphan Drug Designation (ODD) highlights the need for additional treatment options for people...
Czech Humanitarian Groups Urge Condemning Gaza Violations
MENAFN
(MENAFN) Three of the most prominent humanitarian agencies in the Czech Republic have jointly appealed to the authorities to "unequivocally condemn" breaches of international humanitarian law occurring in Gaza, and to object to any proposed...
Curium Announces First Commercial Doses of Diagnostic Radiopharmaceutical in Czech Republic and Slovakia for Patients with Prostate Cancer
GlobeNewswire, Inc.
Curium has entered a partnership with the Czech company ÚJV Řež, a leading expert in the development and production of radiopharmaceuticals, to manufacture diagnostic radiopharmaceuticals for patients with prostate cancer in both Czech Republic...
Captain T Cell Closes Financing Round to Advance its Proprietary, Next-Generation TCR-T Pipeline Into the Clinic
GlobeNewswire, Inc.
Available funding totaling EUR 20 million dedicated to developing novel solid tumor treatments addressing a high unmet medical need Springboard Health Angels, Pluton Asset Holding AG, Sintra Limited, and Technologiegründerfonds Sachsen joined as...
Nanox Collaborates with Leading Czech Medical Imaging Distributor EXRAY to Expand European Footprint
GlobeNewswire, Inc.
EXRAY, leading Czech radiography supplier with 50%+ market penetration, to distribute Nanox’s imaging solutions PETACH TIKVA, Israel, Nov. 06, 2025 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (“Nanox” or the “Company”, Nasdaq: NNOX), an innovative...
Patient coalition launches appeal over plan to restrict CBD: 'Care before discrimination'
EIN Presswire
Patient organisations across Europe and beyond ask the Czech Government and the EU to publish the evidence rather than restrict it quietly.
The 2025 St. Martin's Conference Addressed EU-wide Issues and Czech Competition Policy Tools
Office for the Protection of Competition - Czechia
On 5 and 6 November 2025, the 18th annual St. Martin's Conference on news and current trends in the protection of competition and significant market power was held at the premises of the Office for the Protection of Competition.
GrowGeneration to Exhibit at 15th Annual CannaFest Prague, Showcasing Full Suite of Cultivation Solutions for European Commercial Growers
GlobeNewswire, Inc.
DENVER, Nov. 04, 2025 (GLOBE NEWSWIRE) -- GrowGeneration Corp. (NASDAQ: GRWG) (“GrowGen” or “the Company”), a leading distributor and manufacturer of specialty agriculture products for controlled-environment agriculture (CEA), commercial...
European Union MFGM-enriched Powders & RTDs Market to Hit USD 2.29 Billion by 2035, Driven by Pediatric Health Focus
EIN Presswire
Spain and Italy are set to grow at 8.5% and 8.3% CAGR, driven by strong pharmacy networks, premium nutrition, and pediatric healthcare.
Cosmos Health CEO Issues Letter to Shareholders: Building a Global Healthcare Powerhouse with $300M Digital Financing Facility, U.S. Manufacturing Expansion, and AI Innovation
GlobeNewswire, Inc.
CHICAGO, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that its Chief Executive Officer, Greg Siokas, has...
Winners of the 2025 Esomar Awards are announced in Prague
EIN Presswire
Global brands, agencies, and innovators recognised for groundbreaking work in research, data, and insights at Esomar’s annual Congress PRAGUE, CZECH REPUBLIC, September 30, 2025 /EINPresswire.com/ -- Esomar, the global community for data,...
Alona Lebedieva: Czech Elections May Shift the Balance of Power in the EU
EIN Presswire
KYIV, UKRAINE, October 7, 2025 /EINPresswire.com/ -- In the Czech Republic’s parliamentary elections, the populist ANO party led by billionaire and former prime minister Andrej Babiš, known for his openly Eurosceptic views, scored a victory.
Er-Kim Enters Commercialization Agreement with Sentynl Therapeutics for Nulibry® (fosdenopterin) and Zokinvy® (lonafarnib), Targeting Ultra-Rare Diseases
GlobeNewswire, Inc.
ATHENS, Greece and SOLANA BEACH, Calif., Sept. 24, 2025 (GLOBE NEWSWIRE) -- Er-Kim, an international pharmaceutical company specializing in the commercialization of novel therapies in EMEA region, today announced that it has signed an agreement...
CommonSpirit Health Partners with ESO to Launch First EMS-Hospital Data Exchange in Utah
GlobeNewswire, Inc.
SALT LAKE CITY, Sept. 25, 2025 (GLOBE NEWSWIRE) -- CommonSpirit Health, and ESO, a leading data services and software provider for EMS, fire departments, hospitals, and government agencies, have partnered to improve patient outcomes and empower...
Cooper Pharma marks 90 years with expansion drive to deliver affordable medicines across Africa and the Middle East
EIN Presswire
LONDON, UNITED KINGDOM, September 16, 2025 /EINPresswire.com/ -- Marking its 90th anniversary, Cooper Pharma says its transformation from a Moroccan pioneer into a diversified international group is aimed at cutting costs, creating jobs and...
Sign up for:
Healthcare Press Czech Republic
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.